Similar articles for PMID: 24403474

Year	Number of Results
1998	1
2000	1
2001	1
2002	1
2003	3
2004	5
2005	1
2006	4
2007	2
2008	9
2009	10
2010	11
2011	15
2012	26
2013	27
2014	20
2015	19
2016	10
2017	16
2018	12
2019	18
2020	13
2021	6
2022	8
2023	4
2024	0

1

Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancer.

Hata A, Katakami N, Tanaka K, Takeshita J, Matsumoto T, Monden K, Nagata K, Masago K, Kaji R, Fujita S, Tachikawa R, Otsuka K, Otsuka K, Tomii K. Hata A, et al. Anticancer Res. 2014 Jan;34(1):275-81. Anticancer Res. 2014. PMID: 24403474

2

Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer.

Bonomi PD, Mace J, Mandanas RA, Min M, Olsen M, Youssoufian H, Katz TL, Sheth G, Lee HJ. Bonomi PD, et al. J Thorac Oncol. 2013 Mar;8(3):338-45. doi: 10.1097/JTO.0b013e318282ded5. J Thorac Oncol. 2013. PMID: 23370316 Free article. Clinical Trial.

3

Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.

Reynolds C, Barrera D, Jotte R, Spira AI, Weissman C, Boehm KA, Pritchard S, Asmar L. Reynolds C, et al. J Thorac Oncol. 2009 Dec;4(12):1537-43. doi: 10.1097/JTO.0b013e3181c0a2f4. J Thorac Oncol. 2009. PMID: 19887966 Free article. Clinical Trial.

4

Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.

Cohen EE, Subramanian J, Gao F, Szeto L, Kozloff M, Faoro L, Karrison T, Salgia R, Govindan R, Vokes EE. Cohen EE, et al. Clin Lung Cancer. 2012 Mar;13(2):123-8. doi: 10.1016/j.cllc.2011.10.001. Epub 2011 Nov 18. Clin Lung Cancer. 2012. PMID: 22100149 Clinical Trial.

5

Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).

Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D. Glorieux P, et al. Anticancer Res. 2001 Mar-Apr;21(2B):1487-94. Anticancer Res. 2001. PMID: 11396237 Clinical Trial.

6

Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.

Ramalingam SS, Dahlberg SE, Langer CJ, Gray R, Belani CP, Brahmer JR, Sandler AB, Schiller JH, Johnson DH; Eastern Cooperative Oncology Group. Ramalingam SS, et al. J Clin Oncol. 2008 Jan 1;26(1):60-5. doi: 10.1200/JCO.2007.13.1144. J Clin Oncol. 2008. PMID: 18165641 Clinical Trial.

7

A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.

Paz-Ares L, Bálint B, de Boer RH, van Meerbeeck JP, Wierzbicki R, De Souza P, Galimi F, Haddad V, Sabin T, Hei YJ, Pan Y, Cottrell S, Hsu CP, RamLau R. Paz-Ares L, et al. J Thorac Oncol. 2013 Mar;8(3):329-37. doi: 10.1097/JTO.0b013e31827ce554. J Thorac Oncol. 2013. PMID: 23370314 Free article. Clinical Trial.

8

BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer.

Hainsworth JD, Fang L, Huang JE, Karlin D, Russell K, Faoro L, Azzoli C. Hainsworth JD, et al. J Thorac Oncol. 2011 Jan;6(1):109-14. doi: 10.1097/JTO.0b013e3181f94ad4. J Thorac Oncol. 2011. PMID: 21107290 Free article. Clinical Trial.

9

Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.

Belani CP, Ramalingam S, Perry MC, LaRocca RV, Rinaldi D, Gable PS, Tester WJ. Belani CP, et al. J Clin Oncol. 2008 Jan 20;26(3):468-73. doi: 10.1200/JCO.2007.13.1912. J Clin Oncol. 2008. PMID: 18202422 Clinical Trial.

10

Platinum-Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC.

Michelsen L, Sørensen JB. Michelsen L, et al. Anticancer Res. 2015 Nov;35(11):6255-9. Anticancer Res. 2015. PMID: 26504059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

222 results

Results by year